Farahani, P., S. Khan, M. Oatway, and A. Dziarmaga. “EXPLORING THE DISTRIBUTION OF PRESCRIPTION FOR SULFONYLUREAS IN PATIENTS WITH TYPE 2 DIABETES ACCORDING TO CARDIOVASCULAR RISK FACTORS WITHIN A CANADIAN PRIMARY CARE SETTING”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 22, no. 3, Nov. 2018, https://jptcp.com/index.php/jptcp/article/view/249.